JP2008543729A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543729A5 JP2008543729A5 JP2007558257A JP2007558257A JP2008543729A5 JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5 JP 2007558257 A JP2007558257 A JP 2007558257A JP 2007558257 A JP2007558257 A JP 2007558257A JP 2008543729 A5 JP2008543729 A5 JP 2008543729A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007558257A JP5110697B2 (ja) | 2005-06-27 | 2006-06-26 | 固形製剤 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005187214 | 2005-06-27 | ||
JP2005187214 | 2005-06-27 | ||
JP2007558257A JP5110697B2 (ja) | 2005-06-27 | 2006-06-26 | 固形製剤 |
PCT/JP2006/313176 WO2007001067A2 (en) | 2005-06-27 | 2006-06-26 | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012177601A Division JP5456857B2 (ja) | 2005-06-27 | 2012-08-09 | 固形製剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008543729A JP2008543729A (ja) | 2008-12-04 |
JP2008543729A5 true JP2008543729A5 (es) | 2009-08-06 |
JP5110697B2 JP5110697B2 (ja) | 2012-12-26 |
Family
ID=37460221
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007558257A Active JP5110697B2 (ja) | 2005-06-27 | 2006-06-26 | 固形製剤 |
JP2012177601A Active JP5456857B2 (ja) | 2005-06-27 | 2012-08-09 | 固形製剤 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012177601A Active JP5456857B2 (ja) | 2005-06-27 | 2012-08-09 | 固形製剤 |
Country Status (3)
Country | Link |
---|---|
JP (2) | JP5110697B2 (es) |
TW (1) | TWI388345B (es) |
WO (1) | WO2007001067A2 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6469753B1 (en) | 1996-05-03 | 2002-10-22 | Starsight Telecast, Inc. | Information system |
GT200600371A (es) * | 2005-08-17 | 2007-03-21 | Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas | |
US9113107B2 (en) | 2005-11-08 | 2015-08-18 | Rovi Guides, Inc. | Interactive advertising and program promotion in an interactive television system |
WO2008001734A1 (en) * | 2006-06-27 | 2008-01-03 | Daiichi Sankyo Company, Limited | Compressed preparation |
US20080175872A1 (en) * | 2006-09-28 | 2008-07-24 | Osmotica Corp. | Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid |
US8832742B2 (en) | 2006-10-06 | 2014-09-09 | United Video Properties, Inc. | Systems and methods for acquiring, categorizing and delivering media in interactive media guidance applications |
KR101247583B1 (ko) * | 2006-12-08 | 2013-03-26 | 한미사이언스 주식회사 | 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물 |
TWI414310B (zh) * | 2006-12-26 | 2013-11-11 | Daiichi Sankyo Co Ltd | 溶出性改善之醫藥品組成物 |
TWI488658B (zh) * | 2006-12-26 | 2015-06-21 | Daiichi Sankyo Co Ltd | 溶出性之改善方法 |
TWI402083B (zh) * | 2006-12-26 | 2013-07-21 | Daiichi Sankyo Co Ltd | 固形製劑及其安定化方法 |
RU2493832C2 (ru) * | 2008-01-25 | 2013-09-27 | Дюо-Же | Комбинации пероральных лекарственных средств, соединенных посредством оболочки |
JP5554699B2 (ja) * | 2008-03-13 | 2014-07-23 | 第一三共株式会社 | オルメサルタンメドキソミルを含む製剤の溶出性の改善 |
AR073380A1 (es) * | 2008-09-25 | 2010-11-03 | Takeda Pharmaceutical | Composicion farmaceutica solida. comprimido multicapa |
BRPI0924136B8 (pt) * | 2009-01-23 | 2021-05-25 | Hanmi Holdings Co Ltd | composição farmacêutica sólida compreendendo amlodipina e losartan e método para a preparação da mesma |
CN106176745A (zh) * | 2009-06-30 | 2016-12-07 | 赛诺菲 | 包含厄贝沙坦和氨氯地平的固定剂量的固体药用组合物,它们的制备和它们的治疗应用 |
JP5886530B2 (ja) * | 2010-02-26 | 2016-03-16 | 第一三共株式会社 | 錠剤 |
JP5421945B2 (ja) * | 2010-03-10 | 2014-02-19 | 大日本住友製薬株式会社 | イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物 |
JP5824222B2 (ja) * | 2010-03-31 | 2015-11-25 | 第一三共株式会社 | 固形製剤の製造方法 |
EA025946B1 (ru) * | 2010-10-27 | 2017-02-28 | Крка, Товарна Здравил, Д. Д., Ново Место | Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин |
UY33772A (es) | 2010-12-09 | 2012-07-31 | Lg Life Sciences Ltd | Composición farmacéutica que comprende clorhidrato de lercanidipina y valsartán como componentes activos y a un método para la preparacion de la misma. |
JP6041591B2 (ja) * | 2011-09-13 | 2016-12-14 | 大日本住友製薬株式会社 | イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物 |
WO2014058046A1 (ja) * | 2012-10-12 | 2014-04-17 | 味の素株式会社 | カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤 |
MX2013001277A (es) * | 2013-01-31 | 2014-07-30 | Miguel Ángel García Pérez | Composicion farmaceutica con un antagonista de los receptores de la angiotensina ii y un bloqueador de los canales de calcio para el tratamiento de la hipertension arterial. |
CN103127110A (zh) * | 2013-03-18 | 2013-06-05 | 吉林省博大伟业制药有限公司 | 含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的复方制剂 |
CN103271908B (zh) * | 2013-05-23 | 2019-02-12 | 浙江华海药业股份有限公司 | 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法 |
JP6422868B2 (ja) * | 2013-07-23 | 2018-11-14 | 第一三共株式会社 | 高血圧症の予防又は治療のための医薬 |
CN103908539B (zh) * | 2014-05-03 | 2017-02-01 | 李全浩 | 一种治疗高血压的中药组合物及其制备方法及应用 |
CN104000821B (zh) * | 2014-06-02 | 2020-06-19 | 浙江华海药业股份有限公司 | 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法 |
EP3244880A1 (en) * | 2015-01-12 | 2017-11-22 | Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi | A stable bilayer pharmaceutical tablet compositions comprising fixed dose of irbesartan and amlodipine |
CA3015964C (en) * | 2016-03-24 | 2021-08-03 | Daiichi Sankyo Company, Limited | Medicine for treating renal disease |
CN109432034A (zh) * | 2018-12-28 | 2019-03-08 | 乐普制药科技有限公司 | 一种缬沙坦氨氯地平三层片剂及其制备方法 |
CN110237073B (zh) * | 2019-07-10 | 2022-12-02 | 安庆回音必制药股份有限公司 | 一种奥美沙坦酯氨氯地平片及其制备方法 |
CN114712319B (zh) * | 2022-03-25 | 2024-01-09 | 北京诺康达医药科技股份有限公司 | 一种非洛地平盐酸普萘洛尔复方制剂及其制备方法 |
CN115227662B (zh) * | 2022-06-24 | 2023-11-24 | 辰欣药业股份有限公司 | 一种缬沙坦氨氯地平片剂及其制备方法 |
CN115944600B (zh) * | 2022-12-01 | 2024-05-28 | 山东齐都药业有限公司 | 含有替米沙坦和苯磺酸氨氯地平的口服片剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0859470A (ja) * | 1994-08-29 | 1996-03-05 | Sankyo Co Ltd | シクロペンタ[d]ピリミジン誘導体の溶出性改善製剤 |
US6395728B2 (en) * | 1999-07-08 | 2002-05-28 | Novartis Ag | Method of treatment and pharmaceutical composition |
CZ303145B6 (cs) * | 2002-01-16 | 2012-05-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zpusob výroby dvojvrstevné farmaceutické tablety obsahující telmisartan a hydrochlorthiazid |
WO2003080057A1 (fr) * | 2002-03-27 | 2003-10-02 | Bayer Aktiengesellschaft | Comprime-noyau de taille reduite contenant de la nifedipine |
JP3751287B2 (ja) * | 2002-03-27 | 2006-03-01 | バイエル薬品株式会社 | 小型化されたニフェジピン有核錠剤 |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
JP2004300102A (ja) * | 2003-03-31 | 2004-10-28 | Kissei Pharmaceut Co Ltd | 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途 |
US20050187262A1 (en) * | 2004-01-12 | 2005-08-25 | Grogan Donna R. | Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use |
SI1814527T1 (sl) * | 2004-11-05 | 2014-03-31 | Boehringer Ingelheim International Gmbh | Dvoslojna tableta, ki obsega telmisartan in amlodipin |
-
2006
- 2006-06-26 TW TW095122887A patent/TWI388345B/zh not_active IP Right Cessation
- 2006-06-26 WO PCT/JP2006/313176 patent/WO2007001067A2/en active Application Filing
- 2006-06-26 JP JP2007558257A patent/JP5110697B2/ja active Active
-
2012
- 2012-08-09 JP JP2012177601A patent/JP5456857B2/ja active Active